Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Government of Canada, through the Department of Health, is seeking proposals for the in vitro pharmacological testing of novel psychoactive substances to better understand their activity and associated risks to public health. This procurement is divided into three distinct streams focusing on emerging opioids at the Mu Opioid Receptor, synthetic cannabinoids, and stimulant compounds. The objective is to generate critical data to support scientific regulatory activities and risk assessments by the Office of Legislative and Regulatory Affairs. Selected providers will be responsible for acquiring reference standards and control samples, obtaining necessary licenses for controlled substances, conducting experiments with statistical analysis, and producing final reports. Bidders may submit proposals for a single stream, two streams, or all three, with the possibility of up to three contracts being awarded. The project will be performed within the National Capital Region of Canada.
General Info
Agency
NAICS
Place of Performance
National Capital Region (NCR), CANSet-Aside
Documents
(12)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Government of Canada → Department of Health
Same awarding agency
